According to IMARC Group’s latest report, titled “Sepsis Diagnostics Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2022-2027”, the global sepsis diagnostics market is expected to exhibit a CAGR of 9.2% during 2022-2027. Sepsis diagnostics include immunoassays, molecular diagnosis, microfluidics, biomarkers, and flow cytometry. These diagnostic procedures assist in guiding initial treatment, monitoring the progression of infection, evaluating patient response to the treatment, and reducing symptoms caused due to sepsis. Presently, they are extensively utilized in hospitals, pathology and reference laboratories, and academic research institutes across the globe.
We are regularly tracking the direct effect of COVID-19 on the market, along with the indirect influence of associated industries. These observations will be integrated into the report.
Request a Free PDF Sample of the Report: https://www.imarcgroup.com/sepsis-diagnostics-market/requestsample
Market Trends and Drivers:
A significant increase in the prevalence of hospital-acquired infections (HAI) represents one of the major factors strengthening the sepsis diagnostics market growth. Apart from this, there is a surge in the incidences of infectious diseases around the world. This, along with the growing geriatric population, which is suffering from chronic diseases, is positively influencing the market. Furthermore, leading players are extensively investing in research and development (R&D) activities for identifying and treating chronic infections. They are also developing novel immunological and molecular biomarkers that allow early detection of sepsis, which is creating a favorable market outlook. The market is also propelled by the thriving healthcare sector worldwide.
Sepsis Diagnostics Market 2022-2027 Competitive Analysis and Segmentation:
Competitive Landscape With Key Players:
The competitive landscape of the sepsis diagnostics market has been studied in the report with the detailed profiles of the key players operating in the market.
Some of these key players include:
- Abbott Laboratories
- Becton
- Dickinson and Company (BD)
- biomerieux SA
- Bruker Corporation
- EKF Diagnostics Holding Plc
- Epic Systems Corporation
- Luminex Corporation
- Roche Holding AG
- Sysmex Corporation
- T2 Biosystems Inc.
Key Market Segmentation:
The report has segmented the global sepsis diagnostics market on the basis of diagnosis, product, mode of testing, technology, pathogen, end-user and region.
Breakup by Diagnosis:
- Automated Diagnostics
- Conventional Diagnostics
Breakup by Product:
- Instruments
- Assay Kits and Reagents
- Blood Culture Media
- Software
Breakup by Mode of Testing:
- Laboratory Tests
- Point-of-Care Tests
Breakup by Technology:
- Molecular Diagnostics
- Immunoassays
- Biomarkers
- Flow Cytometry
- Microfluidics
- Blood Culture
Breakup by Pathogen:
- Bacterial Sepsis
- Gram-Positive Bacterial Sepsis
- Gram-Negative Bacterial Sepsis
- Viral Sepsis
- Fungal Sepsis
- Others
Breakup by End User:
- Diagnostic Clinics
- Hospitals
- Research Laboratories
Breakup by Region:
- North America
- Europe
- Asia Pacific
- Latin America
- Middle East and Africa
Ask Analyst for Customization and Explore Full Report With TOC & List of Figures: https://www.imarcgroup.com/request?type=report&id=3090&flag=C
Key Highlights of the Report:
- Market Performance (2016-2021)
- Market Outlook (2022-2027)
- Market Trends
- Market Drivers and Success Factors
- Impact of COVID-19
- Value Chain Analysis
- Comprehensive mapping of the competitive landscape
If you need specific information that is not currently within the scope of the report, we will provide it to you as a part of the customization.
About Us
IMARC Group is a leading market research company that offers management strategy and market research worldwide. We partner with clients in all sectors and regions to identify their highest-value opportunities, address their most critical challenges, and transform their businesses.
IMARC’s information products include major market, scientific, economic and technological developments for business leaders in pharmaceutical, industrial, and high technology organizations. Market forecasts and industry analysis for biotechnology, advanced materials, pharmaceuticals, food and beverage, travel and tourism, nanotechnology and novel processing methods are at the top of the company’s expertise.
Contact US:
IMARC Group
30 N Gould St, Ste R
Sheridan, WY 82801, USA
Website: https://www.imarcgroup.com/
Email: sales@imarcgroup.com
Americas: +1-631-791-1145 | Europe & Africa: +44-753-713-2163 | Asia: +91-120-433-0800
